The cluster is small and dominated by quant/passive players, limiting its signal value. Watch for follow-on filings (new 13Ds or 8-Ks with material agreements/earnings) to see if this buying represents forward conviction.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $59.92entry
- T+1 · 5mo ago +2.34%α +0.57% · $61.32
- T+5 · 5mo ago −1.52%α −2.19% · $59.01
- T+20 · 4mo ago +9.55%α +7.77% · $65.64
- T+60 · 2mo ago +43.31%α +40.04% · $85.87
How similar events traded
Executive Summary
A small institutional cluster of 5 buyers accumulated $15.3M in net new GeneDx stock during Q3 2024, led by Schwab and Point72 doubling their positions. The buying is dominated by quant and passive managers, with no institutional selling, suggesting a cautious but directional vote of confidence in the company's recent strategic pivot.
Key Financial Metrics
Institutional Positions
Net institutional flow: $15.3M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Point72 | ADD | +87.4% | $12.5M | $8.4M |
| Schwab | DOUBLED | +304.3% | $6.2M | $5.3M |
| Citadel | DOUBLED | +229169.2% | $1.3M | $1.3M |
| Legal & General Group | DOUBLED | +680.6% | $360.0K | $332.0K |
| T. Rowe Price | ADD | +34.8% | $3.0K | $1.0K |
Key Facts
- 5 institutional buyers, zero sellers in the cluster
- Net aggregate buying of $15.3M across tracked funds
- Point72 added $8.4M (+87%), the largest dollar increase
- Schwab doubled its position (+$5.3M, +304%)
- Legal & General and Citadel also doubled very small base positions
- T. Rowe Price added modestly (+$1K), a trivial position
- All buying occurred during Q3 2024; 13F data is subject to 45-day lag
Financial Impact
5 institutions accumulated $15.3M in new net position value; total buyer holdings now $20.3M
Risk Factors
- Cluster is small in dollar scale ($15.3M net) and may not move the stock alone
- Point72 and Citadel are quant-driven; positions may already be unwound given 45-day filing lag
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-WGS-2024-Q3 |
Track record
13 reports on WGS
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +63.51% at T+60 after the May 20, 2026 report. 6 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $52.37 settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $54.83 settles Feb 8
- Nov 6, 202610d ago SC 13G Neutral 3/10 Entry $62.37 settles Feb 4
- Sep 18, 20268w ago Insider Cluster Bearish 4/10 Entry $97.83 settles Dec 15
- Sep 11, 20269w ago Insider Cluster Neutral 2/10 Entry $89.74 settles Dec 8
- Sep 1, 202610w ago 144 Neutral 2/10 Entry $86.72 settles Nov 27
- Jun 16, 202621w ago 8-K Neutral 3/10 Entry $60.60 to $83.96 ▲ +38.55% +37.55% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bullish 4/10 Viewing Entry $59.92 to $85.87 ▲ +43.31% +40.04% vs SPY
- Jun 8, 202623w ago Insider Cluster Bullish 6/10 Entry $56.33 to $86.72 ▲ +53.95% +50.14% vs SPY
- May 20, 202625w ago Insider Cluster Bullish 6/10 Entry $47.33 to $77.39 ▲ +63.51% +59.21% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers